Related Experiment Video
Updated: Apr 25, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
Published on: July 11, 2025
New anti-malarial drugs: who cares?
Stephane Picot, Philippe M Loiseau, Anne-Lise Bienvenu1
1Malaria Research Unit, Faculty of Medicine, SMITH, ICBMS, UMR 5246 CNRS-INSA-CPE-UCBL1, University Lyon 1, Lyon, France. anne-lise.bienvenu@chu-lyon.fr.
Abstract:
Most of the people suffering malaria do not know how complex is that disease and how hard searchers are working to fight against it. Some of these people are dying from malaria while still efficient drug combinations should have save their lives. But these drugs were not available for them when needed, or the diagnosis was wrong, or the drugs were fake, or the doctor was untrained, or the patient had no money. Should this terrible reality preclude the need for continuous research to develop new antimalarial drugs? Should people working in laboratories located in non-endemic countries adapt their project to that reality? Malaria eradication, then elimination was announced and broadcasted in the late sixties, and later forgotten. From that failure due to chloroquine resistance and after decades of less arrogant work, billions of dollars are on the table again to claim this goal. There were bed nets, drugs, vaccine and communication as starters, let's hope people in endemic countries will be winners.
Related Concept Videos
Anthelminthic Agents
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Antidepressant Drugs: Overview
Drugs that Destabilize Microtubules
Antidepressant Drugs: MAOIs and Other Agents
Drugs that Stabilize Microtubules

